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The Impact of Time to Thrombolytlc Therapy on 
Outcome In Patients With Acute Myocardial 
Infarction (AMi) 
P, Chareonthaitnwee, RJ, Gibbons, RS, Roberts, TrF Chnstian, R. Bums, 
S Yusut For the CORE Investigators; Ma]K~ Clinic, Rochester, Minnesota, 
USA; McMaMer Unit~erMy, Hami#on, O~tari~ Canada 
Pno~ ~t~m haNe suggested that the greatest t~f i t s  of e<lfly thromboly- 
sis may t~ o~zerv~ if administered within ~ holm of ~y~tom onset+ The 
Ipu~<~ of ~s  i~t ion  wi~ to exan~ne the impact of ~m to ~rom. 
bofy~ ~ on ~ AM! outcome velnaPles in CORE, ~n interr~ltional, 
~ e g  tn~! of pofoxamer 188, Mortal~ (M) 4nd remf4rctmn fate (RR) 
were meaI~red in 2,954 r ~  patients with AMI (.< 12 hogm' d~r~tmn) 
recewed ~ ther4~. S~m~cl~ umng T~em ~tam,t .  
lanai ~ (IS) and reldion~,mhde ~ electron ~ (EF) measured 
by ~mn~'al ~atones  mvOIved I,C~5 and 1,075 patmms, mspact~W, who 
amalyzable ~ .  ~ time to thrombalyttc therapy was ~gmfcantiy 
asso~ated ~ IS, EF, M. ned RR: 
Tume !o Theomtmlys+s 
IS |%LV) 19S t~ I~ 2"25:20  2411 19 2~S ~ 2~ 0.014 
EFt%) 051=.012 04S ¢014 048:013 048¢015 0008 
35~ M 1%) 55 70 77 t2a  00001 
E~t~tt  M |%) 69 S,2 10 1 155 <00001 
35-(t=-y RR t%l 62 32 4 I 09  0 0(~11 
Coe~t~s~ns: 1} There are c~emonstrabM benefits el eadre~ relped~smn 
therapy On m~a~ m..-e, election fradmn, and ~t ty .  2) +~baug~ rite effect of 
tin.re to ff~ron~d~'sis On in~,~'t stze and eiection fracton ~s pnmanly restricted 
to therapy ~ w~thm 2 hours e! sym~om onseL me effect of time on 
mo~alily is evident over all tm~e m~enrats. 3) Re~arctmn rate as htgl~r m 
patients Ireated ~ earker t h ~  t~erapy. 
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~ -~- -~ inRial With the Corvita Endoluminal  
Graft in Peripheral Arteries 
M Hemy, M Amo~. I. Henry. K. Tzvetanov. O. Tncodm. U CC.L. 
Potyctz.,~/ue. Essay-tee-Nancy. France 
Puq3Ose: To evaluate a self--expanding er~olummal vascular prostttes=s, the 
Con.ta Endoluminal Graft (CEG). allewm~ percutaneous bypass gm~ng m 
peni~erel artenes. 
Method and Matenats: The CEG census of 2 ~ n ~ :  a ~t-expand- 
ab~ cyfindncal wire ~ ,  a h~ghly porous, elast¢ coating on ,nner sur- 
face of structure, m wh~-'h b~ood can coagulate, seahng the CEG to form 
a new blood tight vessel wall. This flexible CEG can be compressed atria 
8.-10F introducer sheat'-s a,qo~ng porcutaneeus entry, ts produced an van- 
ous I~gths (3-30 cm). diameters (4 to 44 ram). cut to length by user, released 
from tn~r  sheath at intended site by coa.=al ~ of a "tlof~ng" 
catheter/slew pull back of the introducer sheath 
ResuffS: 58 pts (M: 46, F: 12. mean age: 644 ± 9.7 ym [39-86]) with 
occti.stve lesions (47)(sten.: 28, oocl.: 19), aneurysms (11), in lliac (35). 
temo~opop. (23) arteries treated with CEG. Mean lesion length: iliac~ 58.3 
± 24.3 mm (40-100), lemoropop.: 105.8 ± 7 ram. Mean % steno~s; 79 
± 6.2. 65 stents easily placed percutaneously (10 pts had contralateral 
approach). 6 lesions >12 cm treated ~th 2 overlapped slants. Immediate 
technical success: 100%. Complications: 7 thromboses titian: 2, femoropoD: 
5), 4 les~ons > 15 cm, requinng bypass (3), Fogarty (1). new angioptasty with 
success (3). At 6 months, 3 reslenoses appeared outside the ~iu.; trebled 
by now angioplast~,. Primary I~tency at 1 year: lliac: 95%, fern.pop.: 60% (p 
< 0.00t). Secondary patency respectively: 100, 75% (p < 0.001). 
Conclusion: The CEG seems an alternative to surgery to treat occlu- 
sive lesions and aneurysms, allowing true internal bypass by percutaneous 
approach. Yet, treatment of long lesions leads to higher thrombosis rate. 
~ Renal A 7 Year Single Center Arterial Stenting. 
Experience With a Serles of 206 Stented Artedes 
M Henry, M Amor, I. Henry, K. Tzvetanov, I. Masson, B. Mentre. 
Polyclinique, Essey-les-Nanc~. France 
Pu;pose: To evaluate the role of percutaneous tenting in the treatment of 
renal 9ffenal lestons 9fter failure of previous 10alloon angtoplasty. 
tv~thocl an<1M~tenats. 224 balloon e~panda¢~ steP~ (Palmaz: 164, AVE 
60) placed in 206 renal aNanea of 181 patHmt~ tectal ~ :  140, non. 
oatiol: 66) suffenng from HTN remtant to therapy (181), reflal dy~gnct~n 
(41) with 9theromatou~ (197), tibremu~ut4r (7), "rakay4shu (2) ¢J~ses. 
25 pts had t~laleral esions, 3 a solitary kidney, Ind~-.atmns'. uf~a~factory 
balloon ang~p~ resuits (173), mete.am (26), ~sse~n (7), Mean les~e 
length; 11,9 .+- 4.3 rnm (5-.30), M~n 4tlmo~e %: 623 ± 6.4 (70-100) 14 
very cal01i~ o~!  lemoni treate~ by Rofal01ator, 
~uIP~." gmmed~el~ leche~l success;205/?06,3 major ¢omplc~t~s 
(15%): 1 acu~_ mmm~is  cure¢l by fit~noly~, 1 aelanst perfom~on, 1 
artenal rapture (¢~th after surgery), 6 montt~ el~poo~ foaow.up m 
e l~ pts (175); rosteno~t# in I:~ pts (6.9%), Im~led by el new angmplaety. 
C!,~cal results: systolic blood pmssm drop from (mmH0) 1"/8 ± 9 to 141 
± 12 (p ~ 0,001) pant.slant, ~ ~ preuum (.wVHg) mop from 
106 ± 6 to B2 ± 10 (p .~ 0,01), ¢maumn (n~l) did nol ct~ange, nun~ of 
dmg~patmnt; baseline*. 2,6, pos1-~mt; 1,;2 (p < O,02-J, HTN; cured: 32/161 
(~) ,  iml~'Oved: 98/161 (61%), o~llanged: 30/161 (19%). Henal o~/sh~,~ 
tmn: Improved: 12/41 (30%), u~llanged; 27141 (1~%), ~ ;  ~41 (4%), 
At ? years, at! lesions: i~imary pstency: 76%, aecondary: ~%, non osl~t 
les~nS respectively 78, 100%, Ostlst leS~nS: BO elnd 93% (p:n.s.). 
Conc l~:  Renal aflery stsnting is sale, effe¢tNe, may be an alternative 
to Surgery. partlcutarty in o~tJal esK~ng. Our expenen~e shows md~ction m 
restenomS rote, compared to conventional angmptasty. All ostlal 
~l~ould be slanted. 
~ P ef~utaneous Endolumlnal Treatment of  
m l  Anoul~/ imL A Single Centl~ 
F ~  With e ~k~os of  3S Anouwsms 
M. Henry, M. Arose, I. Henry, K. Tzvetanov, P. Khofer. Po/yc//mque, 
~Na.c~,  France 
Purpose: To evalume fea~l~lfly, efficacy at percutaneous treatment of pe- 
npheral aneuq/sms t0,~th covered stents m most of the cases, Cragg Endopm 
System 1 (CES) and Corvita Endolummal Graft (CEG). 
Meft/o~ and Ma~J/a/s: 33 pts (M: 28, F: 5, mean age: 65.4 ± 9.6 yrs 
H7-83]) ~lh  35 aneurysms treated w~h covered stems (CES: 10, CEG: 13, 
non @ov~red stertts: 2, =i=~i graft: 1). ~ loCatlon: lenlorel ~'~.  
12. poplrteal: 8, d~c:15. Mean leslon length.61.1 mm± 21.3. Percutaneous 
approach used m all cases, femoral antegracle (n = 19), lemofal retrograde 
(n = 14), fern_ coqntralateral (n = 1). poptrteal (n = 1). Sten~ are ~tre~uced 
tt~ougll 7-10F st~eattts. Multiple slenl~ used to cov~r all les~ns in 8 cases 
Slants: from 6 to 12 mm in diameter, frem 30 to 120 mm in length. 
Re~.d~: Sten~ ~ implanled in 34 cases, no leakage. In 1 long, 
very tot'gJot~ femoropopliteal aneurysm, m'q3o~e to cover rts low pint. the 
dewce (CES) being too ng~d. No complication bserved unng the procedure. 
3 of 5 0evek~ non-+nfecllo~s fever/local pain with CES. 5 mremboses: 3 
in a palm,teal ane~ t in a femoral aneu~s,m treated by bypass, 1 In an 
thac aneu~am treated by Fogady techn=que. All othe~ slenis remaon patent, 
the aneuWSm completely exclucled o~er a mean follow-up of 13.3 ~ 10.4 
and a max. folfow.-up of 46 rrm:~m. Primary palency at 42 months: 
all Insane: T~=, ili~c ~teurysms: 100%, femoral aneurySm: 91%, poplttoat: 
34%. Secondary patertcy: all lemons: 85%, iliac aneurysms: 100%, femoral: 
91%. po~liteal- 56%. 
Cor~usnon: Percutaneous endelummal treatment of pen~ral  aneurysms 
seems safe. effect~e, effanng t~gh technical success with good told+term re- 
sults, except tot poptPeal ecalization. Long term result~ need to ba analyzed. 
Thts method could be an altematwe to surgical bypass and may be the first 
treatment o propose for this kind 01 disease. 
~ Percutaneous Endoluminal Treatment of 
Aorta-Abdominal  Occlusive Diseases 
M. Henry, M. Amor. I. Henry, K. Tzvetanov, B. Mentre, D. Weill. UCCI.. 
Pofycl/nKTue, Essey4es.Nancg France 
PurpOse: To evaluate the feasibility and efficacy of percutaneous endoluminal 
treatment of aorta-abdominal occlusive diseases. 
Methc~ and Materfafs: 28 pts (M: 25, P 3, mean age: 52.5 ± 11 3 ym) 
were treated by Percutaneous Transluminal Angtoplasty' (PTA) tar aorta- 
abdominal occluswe diseases. Lesions were located in the infremnal aorta 
alone (stenoses: 12). or extended 1o lilac artenes (stanoses: 12, occlusions: 
4). Mean % stenosiS: 80.4 ~_ 11.7. Mean lesion length: 33.5 ± 7.2 ram. 
7 lesions were calcified, 9 ulcerated. 16 excentrated. Owing to Fontatrm's 
clasmtication, 26 ~ were in stage It severe, 2 in stage III. 
Resu/ts: Technical success in al: cases (100%). The 4 oo:lusions were 
initially treated with tibnnolysis (3) or ultrasound mechanical thrombectomy 
device (1). Stentts were implanted in 23 pts (Palmaz in 18 pts, Wallstent 
in 2 and Optimecl in 3). A.B.I. increased from 0.63 :~ 0.15 to 0.97 ± 0.05. 
No immediate complication. Max. follow-up: 9 years, mean follow-up: 26.4 
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months, At 3 yrs, we report 2 rostonosos, 1 treated by PTA alone, 1 by PTA 
and stent. All arteries remained patent, 
Conclusion: PTA el infrarenat aorta. ,)cctt.lSlVO dlse~, ;os is sate and cOco- 
live Slant placement are necessary In most el the cases, Leng term results 
ar~t o~collent This technique is an alternative to surgery 
"o"' So.ported C..o,,d Ang, op,.,y (..CA) In 
. . . . . . . . . . . . . .  Patients With Symptomatic Coronary Artery 
Disease: Acute and Long Term Results 
F/A, Shawl, A, Efstrotieu, F, Lapetlna, A, Dukevoic, T, Shahab, 8,B, Heft, 
K,G, DO~lghnrty, Wa,~hingtorl Adventist H&~piIal. dikes# Prqrk. MD. USA 
C~rolid endarteroctomy (CE) in tl~fl pro~onco el r~ymptomatte coronary artery 
disease (SCAD) has boon associated with high molbidily and mortality Of 
06 pie with SCAD who undnrwenl SSCA, 77 were conaiderod poor CE 
candidates (g had scent MI, 27 had 8ovate LV dy~lunclien with Class III or 
IV nngina pre~ent in 50), Twenty leHt wore ,g0 years, 0 l~nd eontralatorol 
carotid o~oluslen, 20 had bilateral atano~is. 70%, 52 presented with TIA's or 
eVA, 5 scent h~miplegla, and evolving stroke was prose~t In t, ~CA was 
undaftakon in g0 internal and 7 common carotid artenea with implanlatlca el 
14t Palma~, stent~ with everlappieg sleet in 33% to Incroaae radial stronglh. 
Pmeed~lr~l succo,~ we~ff 100% (tl~(:;l~ldlnt155 w!th combiner4 or at~god PTCA) 
rodllclng the carotid Me.healS from 86 t 7% to 5 ~ 2% There were no deaths, 
MI or meier strokes, hut, 3 pts l~r~d miner neurolofllc deficit which resolved 
in 7 day& Moat (75%1 were discharged within 24 hetlrs, On fellow.up (g t 
5 months), 6 p16 died teen combrava~c~dl~r) and 2 with known LV tl~mmbus 
so(feed minor ~trekn In 71 p(s eligible for 6 monll~ anglograplric (4~ pts) 
of uttr~se~,md (Tt pts) follow.up ~eveidcd, t asymptomatic ioslenotHs, wl~lch 
wa~ ro.diltUed 
Conchrsien: SSCA is associated with n high success tats, low recurrence 
rat~ and infrequent complications, 
L~8:~ Is Combined Parcutaneous Carotid Artery 
- Slanting and Coronary or Extra-Coronary Artery 
Angloplasty a Safe Procedure? 
JC. Laborde, J, Faiadet, B Cassagnoau, C Jordan, R Calms, T Joseph, 
J P Laumnt, J Memo Unitd de Cmdlotoqie Infen.ent~onnelle, Chn~que 
P&~ltr, TouletL~o, F~anct~ 
Background: To evaluate the risks and bnnohts el carotid orient stontmg m 
comhtnation with coroner's, or oxtra-c"~renary angioplasty dunng the same 
setting in patients at risk for ondartorectomy. 
Mefhc~d.~ From 4/15/96 to 7,'20197, we pertormod combmed procedures 
tn 22 pahonts ( t 8 males, mona ago 71 2 t 4 ? years, range: 62-78), consid- 
ered at nsk fo~ su~tcal ondarlorectomy Assoclahon of caretid stontmg and 
coronary ang~oplasty (balloon +stont: 5 pts, balloon angloplasty atone: 4 pls, 
3therectomy + balloon 2mq~oplasty 1 pt) was performed in 10 pts, bilateral 
camt~d stontmg ,~ 9 pts; carehd slenlmg ar(d ponphoral angloplasty (renal 
stentmg: 1 pt; ihae stenhng: 1 pt; femoral angloplasty: 1 Dr) in 3 pie. Twelve 
pts (55%'t had neurologlc symptoms incladtng transient ischomic attacks (8 
pts) and recent stroke (4 pts). The remaining pts wore asymptomatic. Twenty 
pts (91%4 had severe coronary associatod orion,/lesions. Moan diameter 
stonosls of the carehd Ios~ons was ?9"0 frange: 65-95%). All pabonts wore 
treated without downtlow carotid protection. 
Results: Procedural success was achieved ~n 21/22 Dis (955%) Imme- 
diate comphcahons conmsfed ot 1 rumor stroke (45%,) At 30 days follow-up, 
we obsewod one death t4,5",,) duo to cardiac arrest, non fatal cardiac events 
m 2 pts (1 heart lailure, 1 ventncular tachycardia), 1 abdominal haemorrago, 
no MI, no stroke. At follow-up, mean 5,7 t 4.1 months, we observed { 2 
cardiac deaths, 2 PTCA for restonoms, no MI, no stroke 
Conclusfons: Combination of carotid artery stentlng with controlatoral 
carotid stoat implantahon or w~th coronary and extra-coronary angtoplasty 
dunng the same setting appeared not to mcrease significantly the ask el 
carotid stenting in high-risk pts lor surgery, 
~ L a c k  of Benefit of Stentlng Compared to Bal loon 
Angloplasty for Native Coronary Stenoses in 
Diabet ics  
M.H. Ghatoun, GC. Timmls. T, Catlin, D, Aliabadi. R+D. Safian, 
J.A. Goldstem, W.W O'Neill Wdliam Beaumont Hospital. Royal Oak, 
Mich.gan. UqA 
As suggested m recent teals of balloon angioplasty vs bypass surgew, di- 
abetic patients may tare less well with angioplasty, Intracorenary stenting 
reduces restenosis rates in pts undergoing elective angioplasty of native 
coronary stenoses. However, whether stenting conlers such benefits in dia- 
betics has not been established. Therefore, we retrospectively analyzed the 
outcome over 9 months in diabetic patients undergoing balloon angioplasty 
alone (N = 154) or elective stonting (N ~ 87) of native coronary lesions, End- 
points el the study included target vessel rovascularizatlon (TVR) and major 
clinical outcomes (MI, stroke and death), No differences wee found between 
groups with aspect to ago or gender. Acute success rotes between balloon 
nnd stont groups were similar. Over 9 months, them wee no ai~niflennt 
difference between angioplasty end stent groups with regard to TVR roto~ 
(24% vs 28"/0, P = NS), MI (4,3% vs 3,8% P ~ NS), stake (P,~, vs 9.6%, P 
== NS) or death (? R"/,, v~ .q,2%, P = NS), These data suggest that oomparod 
with balloon nngioplaaty, elective intmooronaly stenting dens not provide 
additional benefit in diabolic pts undergoing percutanoega rovascgl~nZ~tlon 
el nntive ceronnry lesions, The moat elteCtlVe revaact!!rletolion strategy for 
tl~nso pts has not boon dotetmmed 
' ==== ~---' (111]I]~B4 j The Effect of Dlel~tee and Revas©u!er!zetlon 
+ - - ~  Technique on Eerly Outcomes 
GC Timmia, R T Collie, L Tomaka, W.W, O'Ned! Wtlham B~+umont 
Hospffal, Revel/Oak, MI, US.4 
Beeal.lse el the interaction at diabetes (DM) and mvasculalizattee technique 
on eulcomea we interrogated our !nt~n/onhenal Outcomes Regtst~ Database 
tel the following In,hospital events: death, IofalClion (b(3lh qMI and nqMl) 
SllOkO, lllgellt 6lllglca! levascu!arl~aften, ca~iel~nl~ shock~ and reoo~Iuslon 
a~ inlhteeced by DM status (beth type I and II) m~d by procedure (PTCA 
vs sleet) There were 17',00g patients (pts) having procedures tree t,1,94 
Ihreugh 3,31-97, 4,056 (29%) were diabetic (type Iaad It) but stmdar m age 
gender and disease seventy There wore 62 and 104 doatbs m the OM v,s 
non.DM pls (1 25%, vS 0.86%; p = 0.01 cJ). This was duo to an eKcess mo~akty 
m PTCA pts with DM (1,22% vs 0.83% non, DM PTCA pts; p = 002.5) There 
was no slgndleant mortalLty dlllemn¢o in sleeted DM vs non-DM pts tt 48% 
vs 1 05%; p =, 0.3g) Roocclusions wore mere likely to complicate PTCA 
regardless el the presence o! DM (1.68%, vs 0.49% with stoats; p = 0032) of 
Its ab~enc~ (t 7~i% vs O~ 75% wtth stoats; p = O.OOt/ Converser K MIs ¢~'re 
more lreqnont with stents (2.33% vs 1.29%; p = 0.000) but wore equally 
dlstnbuled beh~oon DM and non-DM pts regardless el procedure ~,~reover, 
combining ~lt endpomts there was no stgmllcant difference per d~abot~c status 
(p = 0.38) regaElloss ot procedure (stool: p = 027; PTCA: p = 0.48). No other 
ondpetnt wos intktonced by DM status Iocludmg acute or delayed reoccluston 
Conclusion: Hospital mortality is higher in OM pts alter PTCA but not alter 
stealing. However, the combined endpoint was not influenced by diabetic 
status bul rather by procedure mcluding polar differences in reoo=lusmn and 
MI, These early outcemes unno~score the importance el adiunchve therapy 
~1_8-8~ Predictors of Target Lesion Revascularization in 
- -  Diabetic Patients Treated With Palmaz-Schatz 
Stents 
A AbzzaLd, G.S Mmtz, B Otlaca. KM Kent, L F Sailer. A O Plchard. 
H Wu, R Mehran, T Bucher, J J Popes, M B Leon Washmgton Hospital 
Center, Washmgton, DC USA 
To ovahtate the predicterS el target leslol~ ~eva~culartzatlon (TLR) m diabetics 
treated w~th Palma=-Schatz stoats, t 51 native vessel lesions m 130 consec- 
utwe pts were analysed using ( lt  pre and post-intervention mtravascular 
ultrasound (IVUS: reterence and lesion ar(eeal, lumen, and plaque areas 
and plaque burden (plaque/adenal area)} and t2) quanhtative angtography 
{QCA: relorence diameter, mmimum htmen diameter (MLD), and diameter 
stonosis (%DS)}. All pts were followed for at least 1 yr. Univanate predictors 
included 
TLR no TLR p 
N 39 112 
h ,:,oh~'l Iher3py 61 ~o 44% O 001 
QCA 
R~lelelIce 2 95 t 0 F,8 3 10 t 0 66 e 05 
Pest MLDt%) 268 '~ 049 294 : 066 003 
IVUS 
Rt!tetel~t~ lumer~ area tan12) 7 50 .* 1 79 9 57 t 3 48 000t 
Referenceplaque bulden 52 t 12 47 : 12 0066 
Postleslon lumen area tam ?) 6 70 .* 1 74 7 53 t 2 57 0 02 
Post MLD (am) 2.55 t O 28 2 76 t 0 52 0 002 
Insulin-treated diabet,cs had a TLR rate of 3t°o (vs 19% for non-insulin 
diabetics). Using multivariate logistic regression analysis, the mdependent 
predictors of TLR were insulin therapy (Odds ratio = 0167. p = 0.048) and 
IVUS final lumen area (Odds ratio = 0.034. p = 0.011). 
We Conclude: Diabetic pts, especially those treated with insulin, have a 
high rate of TLR 1 yr after stent placement (25% overall, 31% for insulin- 
treated diabetics). However. even in these pts the IVUS final lumen CSA is 
an important predictor of late events. 
